4.8 Article

Black hollow silicon oxide nanoparticles as highly efficient photothermal agents in the second near-infrared window for in vivo cancer therapy

Journal

BIOMATERIALS
Volume 143, Issue -, Pages 120-129

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2017.07.037

Keywords

Silicon oxide; Non-stoichiometric ratio; Localized surface plasmon resonance (LSPR); The second near-infrared (NIR-II) window; Photothermal therapy

Funding

  1. National Key Research and Development Program of China [2017YFA0205304]
  2. National Natural Science Foundation of China [81371645, 81471716, 31400861, 81671782]
  3. Science and Technology Committee of Shanghai [15PJD020, 15441905800, 16JC1400604]
  4. Natural Science Foundation of Jiangsu Province [BK20140320]
  5. Medicine & Engineering Cross Research Foundation of Shanghai Jiao Tong University [YG2014MS33]
  6. Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)

Ask authors/readers for more resources

Semiconductor nanoparticles with localized surface plasmon resonance (LSPR) have gained increasing interest due to their potential for use in nanomedicine, particularly in the area of cancer photothermal therapy. In this study, we have synthesized non-stoichiometric hollow silicon oxide nanoparticles (HSiOx NPs) using a magnesiothermic reduction process. The black NPs generated a desired LSPR in the second near-infrared (NIR-II) window, as was demonstrated by a photothermal conversion efficiency of up to 48.6% at 1064 nm. Such an efficiency is the highest reported among the noble metal and semiconductor-based NPs as NIR-II PTT photothermal agents. In addition, H-SiOx NPs exhibited excellent in vivo photoacoustic (PA) imaging properties, and thus can be used for highly efficient in vivo cancer treatment via irradiation with a 1064 nm laser, even at 0.6 W cm(-2). The findings described are the first to demonstrate the existence of LSPR in non-stoichiometric silicon-based nanoparticles with a low-toxicity degradation pathway for in vivo application, and provide new insights towards understanding the role of new semiconductor nanoparticles in nanomedicine. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available